文献速递神经肿瘤

WHO-2级脑膜瘤全切与次全切术后辅助分次放疗的多中心回顾性队列研究

Fractionated radiotherapy adjuvant to surgery of WHO-2 meningioma with and without gross total resection: a multicenter, retrospective cohort study of 1,452 patients.
PubMed 文献 · J Neurooncol · 2026-02-09

该多中心回顾性队列分析1452例WHO-2级脑膜瘤患者,评估辅助分次放疗(aFRT)对复发和生存的影响。全切(GTR)后aFRT未显著降低复发风险(最大差异−2.7%,95%CI −5.6至0.2),但次全切(STR)后aFRT与复发风险降低相关;GTR后放疗组死亡率意外升高,主要由老年低Ki-67患者驱动。

要点

  • GTR后aFRT未显示明确复发获益,但置信区间包含小获益可能。
  • STR后aFRT在未调整和调整分析中均与复发风险降低相关。
  • GTR后接受aFRT的老年低Ki-67患者死亡率较高,需谨慎选择。

核心结论

  • STR后aFRT一致降低复发风险,而GTR后复发风险估计不一致。
  • GTR后aFRT未显著降低复发风险,但置信区间包含小获益可能。
  • GTR后接受aFRT的患者死亡率较高,主要由老年低Ki-67患者驱动。

研究设计与样本

  • 国际多中心回顾性队列研究,纳入1989至2019年随访的1452例WHO-2级脑膜瘤患者。
  • 采用竞争风险和生存分析,通过G-computation估计平均治疗效应,调整年龄、性别、Simpson分级、Ki-67指数、部位、国家组和治疗起始年份。

主要发现

  • 1452例中276例(19.0%)接受aFRT。
  • GTR患者中,未调整分析5年内复发比例放疗组25.5% vs 未放疗组22.8%。
  • 调整分析最大差异为−2.7%(95%CI −5.6至0.2),无证据表明aFRT降低复发风险。
  • STR患者中,aFRT在未调整和调整分析中均与复发风险降低相关。
  • GTR放疗组死亡率较高,主要驱动因素为老年低Ki-67患者。

临床怎么用

  • STR后可考虑辅助分次放疗以降低复发风险。
  • GTR后辅助放疗需个体化决策,尤其老年低Ki-67患者应警惕潜在死亡率升高。

局限性

  • 回顾性设计,缺乏标准化指南,存在选择偏倚可能。
  • GTR患者敏感性分析结果存在差异,结论需谨慎解读。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The role of adjuvant fractionated radiotherapy (aFRT) after gross total resection (GTR) of WHO-2 meningiomas remains unclear. We aimed to estimate the effect of aFRT on recurrence risk and survival following GTR and subtotal resection (STR). METHODS: We analyzed 1452 patients with WHO-2 from our international, multicenter database (followed between 1989 and 2019). Outcomes were recurrence (10-year follow-up) and death (5-year follow-up). Risk estimates were obtained using competing risks and survival analysis. Average treatment effects were estimated by G-computation, adjusted for potential confounding by age, sex, Simpson grade, Ki-67 proliferation index, location, country group (universal healthcare or not), and year of treatment initiation. The robustness of findings was examined through sensitivity analyses. RESULTS: Overall, 276 of 1452 patients (19.0%) received aFRT. Among GTR patients, unadjusted analysis showed comparable recurrence proportions between irradiated and non-irradiated patients (25.5% vs. 22.8% within 5 years). Adjusted analyses provided no evidence that aFRT reduced the risk of recurrence (largest difference: −2.7%, 95% CI −5.6 to 0.2); although, the CIs include the possibility of small beneficial effects. In STR patients, aFRT was associated with reduced recurrence risk in both unadjusted and adjusted analyses. Unexpectedly, a higher mortality was observed among irradiated GTR patients, largely driven by older patients with low Ki-67 PI receiving aFRT. Sensitivity analyses showed similar results for patients with STR but discrepancy in estimates for those with GTR. CONCLUSION: Adjuvant FRT showed a consistent reduction in recurrence risk after STR while inconsistent recurrence risk estimates were observed for patients with GTR. The findings reflect efficacy of aFRT using real-world data without standardized guidelines.

来源:J Neurooncol,查看原文。版权归原作者所有。

引用

  1. Mirian C, Jensen LR, Hoffmann AG, et al. Fractionated radiotherapy adjuvant to surgery of WHO-2 meningioma with and without gross total resection: a multicenter, retrospective cohort study of 1,452 patients. J Neurooncol. 2026. PMID: 41661453. doi:10.1007/s11060-025-05349-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。